Paul Rennie, Chairman & Managing Director at Paradigm Biopharmaceuticals Ltd., holds 20.68M shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF), holds 1.09M shares in Neuroscientific Biopharmaceuticals Ltd. (Ticker: AU:NSB). Most recently, Paul Rennie Bought ― shares of Paradigm Biopharmaceuticals Ltd. on Nov 30, 2023 for an estimated value of 200.38K.